Skip to main content
Clinical Trials/NCT03255499
NCT03255499
Unknown
Not Applicable

Efficacy of the MovinCog Intervention in Children: A Randomized, Placebo-controlled Trial

University of Auckland, New Zealand1 site in 1 country1,000 target enrollmentSeptember 10, 2017

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Learning Disorders
Sponsor
University of Auckland, New Zealand
Enrollment
1000
Locations
1
Primary Endpoint
Change from baseline working memory capacity at 10 weeks
Last Updated
5 years ago

Overview

Brief Summary

This study aims to test the efficacy of the MovinCog Intervention to enhance cognitive abilities in children 7-15 yrs. The intervention consists of two parts: a physical exercise regimen, based on high-intensity training, and a cognitive training component. The design will contrast the intervention with an active control group, matched for expectancy effects.

Detailed Description

Specifically, the investigators will compare both components together (exercise and cognitive training) against either one of the components (exercise alone, or cognitive training alone) and against an active control group. The study will include measures of scholastic aptitude, as well as of working memory and cognitive control (primary outcome measures), two cognitive abilities that are critical to daily life activities, and that respond well to training. In addition, the investigators will measure physiological responses to training, to monitor changes associated with exercise (secondary outcome measures). Finally, the investigators will relate training-specific improvements with transfer gains, to better model the interaction between training and transfer. This will provide a comprehensive understanding of the dynamics associated with the intervention.

Registry
clinicaltrials.gov
Start Date
September 10, 2017
End Date
December 31, 2021
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
University of Auckland, New Zealand
Responsible Party
Principal Investigator
Principal Investigator

David Moreau

PhD

University of Auckland, New Zealand

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Age outside inclusion criteria
  • History of seizures, brain trauma

Outcomes

Primary Outcomes

Change from baseline working memory capacity at 10 weeks

Time Frame: Baseline and 10-week posttest

Constructs measured by multiple tasks (bds, corsi, n-back)

Change from baseline cognitive control at 10 weeks

Time Frame: Baseline and 10-week posttest

Constructs measured by multiple tasks (flanker, go/no-go, stroop)

Change from baseline scholastic aptitude at 10 weeks

Time Frame: Baseline and 10-week posttest

Constructs measured by multiple national (New Zealand), standardized tests

Secondary Outcomes

  • BDNF polymorphism measured by genetic saliva kit(Baseline)
  • Change from baseline resting heart rate at 10 weeks(Baseline and 10-week posttest)

Study Sites (1)

Loading locations...

Similar Trials